American College of Allergy, Asthma and Immunology (ACAAI)

Recognizing Your Asthma Is Not Well Controlled Is the First Step in Controlling it

What are the signs you may need to get your asthma under control?

Newswise — ARLINGTON HEIGHTS, Ill. (April 23, 2020) – It’s a familiar story to allergists. They meet a patient with asthma who, when asked if their asthma is well controlled says, “Absolutely.” But once the patient has answered a few more questions, it is revealed that their asthma is not at all well controlled. Especially as asthma patients around the world deal with COVID-19, staying on course with their regular treatment in order to keep their asthma under control is more important than ever.

“Unfortunately, many people who suffer from asthma don’t recognize what well-controlled symptoms look like,” says allergist J. Allen Meadows, MD, president of the American College of Allergy, Asthma and Immunology (ACAAI). “They think it’s the normal course of asthma to have symptoms that don’t really go away or to need your quick relief inhaler more than two times in a week. May is Asthma and Allergy Awareness month. It’s the perfect time to impress upon everyone the importance of keeping asthma under control in order to lead a healthier, more active life. Everyone with asthma should be a full participant in all life’s activities, without compromise due to issues with breathing!”

Following is information ACAAI wants you to be aware of as you work toward controlling your asthma:

Stay on your meds - With the COVID-19 pandemic coinciding with the Spring allergy season, you may be concerned about using your intranasal corticosteroids for nasal allergies and your inhaled corticosteroids for your asthma. There is no data to suggest that continuing these allergy and asthma medications will have any effect on increasing your risk of getting the COVID-19 infection or if you get the infection, lead to a worse outcome. It is important to control your allergy and asthma symptoms as they could potentially lead to misdiagnosis of COVID-19 if there were an overlap of some symptoms. 

Allergists are specially trained to treat your asthma – Studies reveal most children and adults with asthma don’t see an allergist – a specialist who could improve their symptoms. Allergists take a detailed history and can do testing to identify your unique set of triggers and symptoms. They can also create a customized asthma plan to help you recognize when your symptoms are telling you to pay closer attention to your treatment. A visit to the allergist can help you identify what changes might be necessary to improve your symptoms.

The “Rule of Twos” is “too” important – Do you know the “rule of twos?” If you reply yes to any of these questions, it’s time to talk to your allergist about whether your asthma is under control.

  • Do you have asthma symptoms or use your quick relief inhaler more than two times a week?
  • Do you wake up at night with asthma symptoms more than two times a month?
  • Do you refill a canister of your quick relief medication more than two times per year?

Also note if you:

  • Have had a life-threatening asthma attack.
  • Have symptoms that are unusual or hard to diagnose.
  • Have hay fever or sinus infections that can complicate asthma.
  • Have been admitted to a hospital because of asthma.

Immunotherapy (allergy shots) can help asthma – Asthma and allergies are closely connected. About two-thirds or more of those with asthma also have an allergy, and people who have allergies often also have asthma. Immunotherapy in the form of allergy shots or tablets can reduce sensitivity to the allergens that trigger asthma attacks and significantly reduce the severity of the disease. It might even prevent the development of asthma in some children with seasonal allergies.

There are new asthma treatments you may not know about – You may have heard about a newer type of drug called biologics but not realized they can be used to treat asthma. Asthma is one of the most common conditions for which biologics can be prescribed. While biologics don’t cure asthma, their use can lead to better control. Presently, there are five biologics approved for asthma. They are intended for severe asthma that is not responding to inhaled medications or in patients who require frequent or chronic use of oral corticosteroids like prednisone for their asthma. Talk to your allergist if you think you may meet these criteria.

To find an allergist near you who can create a personal plan to deal with your allergies and asthma, and help you live your best life, use the ACAAI allergist locator.

About ACAAI

The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.

 

 

 




Filters close

Showing results

110 of 3699
Released: 19-Oct-2020 4:20 PM EDT
Patients Who Had More Severe Covid-19 May Be the Best Donors for Convalescent Plasma Therapy
Johns Hopkins Bloomberg School of Public Health

Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease.

access_time Embargo lifts in 2 days
Embargo will expire: 20-Oct-2020 10:00 AM EDT Released to reporters: 19-Oct-2020 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Oct-2020 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Oct-2020 3:05 PM EDT
Experts haven’t changed their estimates for COVID-19 immunity duration, despite Trump's claim
Newswise

We rate this claim as mostly false. Infectious disease experts did not shift from saying immunity was lifelong to saying it lasted only a few months for partisan reasons. Experts haven’t changed their estimates for immunity duration, which remains unknown. Most agree that it is not a "life-time".

Newswise: 246157_web.jpg
Released: 19-Oct-2020 1:50 PM EDT
CBD helps reduce lung damage from COVID by increasing levels of protective peptide
Medical College of Georgia at Augusta University

One way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of this storm.

Released: 19-Oct-2020 1:35 PM EDT
Fear of COVID-19 raises risk of depression among Soweto's deprived communities
Cambridge University Press

A STUDY into the impact of the COVID-19 lockdown on the mental health of people in Soweto has found a significant link between symptoms of depression and how likely people felt they were to be infected.

Released: 19-Oct-2020 1:25 PM EDT
Coronavirus Test Results Are Faster but Still Too Slow For Contract Tracing, National Survey Says
Rutgers University-New Brunswick

The average test times for coronavirus results have fallen from four days in April to 2.7 days in September, but results are still too slow for effective contact tracing, according to a new nationwide survey led by researchers from Rutgers University–New Brunswick and Northeastern, Harvard and Northwestern universities.

Newswise: 246236_web.jpg
Released: 19-Oct-2020 1:15 PM EDT
Researchers investigate impact of COVID-19 on BAME businesses
Staffordshire University

Black, Asian and Minority Ethnic (BAME) businesses have had to incur considerable costs to protect their businesses through lockdown, according to academics at Staffordshire University.

Released: 19-Oct-2020 1:05 PM EDT
Criteria to predict cytokine storm in COVID-19 patients identified by Temple Researchers
Temple University Health System

Like a cold front that moves in, setting the stage for severe weather, coronavirus infection triggers showers of infection-fighting immune molecules - showers that sometimes escalate into a chaotic immune response known as a cytokine storm.

Newswise: 246249_web.jpg
Released: 19-Oct-2020 12:55 PM EDT
COVID-19 pandemic has dramatic impact on osteoporosis management, finds new global study
International Osteoporosis Foundation

A new study published prior to World Osteoporosis Day finds that the COVID-19 pandemic, which has severely affected management of non-communicable diseases, is markedly impacting the management of osteoporosis as judged by access to online FRAX fracture risk assessments.


Showing results

110 of 3699

close
0.99919